|Articles|July 2, 2023
- Pharmaceutical Executive: July 2023
- Volume 43
- Issue 7
Pharmaceutical Executive, July 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
Crossing the Brain Barrierabout 3 years ago
Biotech’s Survival Story: Companies Bear Down for Lean Yearsabout 3 years ago
Harnessing AI for Pharma Salesabout 3 years ago
Tapping New and Improved Drug Innovations in Asiaabout 3 years ago
Drug Shortages Continue to Plague FDA, Manufacturersabout 3 years ago
Contrasting Aims Highlight Pharma Reform Pursuitsabout 3 years ago
Shifting Macro Trends Offer Hope for Biotech Performance Boostabout 3 years ago
‘Bolus’ Markets: Unique Business Opportunities with Promise and RiskAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
2
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
3
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
4
Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD
5